Product Description: EGFRvIII peptide is an EGFRvIII-derived epitope for binding to MHC I molecules. EGFRvIII peptide induces apoptosis, and causes specific immune responses against glioblastoma, especially in combination with Flagellin B[1].
Applications: Cancer-programmed cell death
Formula: C48H78N12O16
References: [1]Choi JM, et al., Flagellin synergistically enhances anti-tumor effect of EGFRvIII peptide in a glioblastoma-bearing mouse brain tumor model. BMC Cancer. 2022 Sep 15;22(1):986.
CAS Number: 916850-24-3
Molecular Weight: 1079.20
Research Area: Cancer
Target: Apoptosis